While diet and exercise remain key pillars in managing weight, injectable weight loss drugs such as Mounjaro, Ozempic, Wegovy, and Zepbound provide a new pathway for people dealing with diabetes or obesity. These medications offer significant promise, but you may have a lot of questions about how they work, how effective they are, and which one is right for you. Below, we break down the similarities, differences, and benefits of each medication, and answer common questions about side effects, costs, and usage.
| Medication | Generic Name | Minimum Age | Drug Class | Approved Usage(s) | Prescribed Usage(s) |
|---|---|---|---|---|---|
| Mounjaro | Tirzepatide | 18 | GLP-1 and GIP receptor agonist | Type 2 diabetes | Type 2 diabetes/overweight/obesity |
| Ozempic | Semaglutide | 18 | GLP-1 receptor agonist | Type 2 diabetes/heart disease prevention* | Type 2 diabetes/heart disease prevention*/overweight/obesity |
| Wegovy | Semaglutide | 12 | GLP-1 receptor agonist | Overweight/obesity/heart disease prevention** | Overweight/obesity/heart disease prevention** |
| Zepbound | Tirzepatide | 18 | GLP-1 and GIP receptor agonist | Overweight/obesity** | Overweight/obesity** |
* Approved for adults with type 2 diabetes and known heart disease.
** Approved for adults with overweight or obesity and at least one other weight-related condition.
Semaglutide is the active ingredient in Ozempic and Wegovy, and it works as a GLP-1 receptor agonist to treat type 2 diabetes and assist with weight loss. Tirzepatide, the active ingredient in Mounjaro and Zepbound, also addresses type 2 diabetes and promotes weight loss. However, it activates both GLP-1 and GIP receptors, making it a more powerful dual-acting agent.
Although Ozempic and Wegovy contain the same active ingredient (semaglutide), they are prescribed for different reasons:
Both medications have similar side effects, including nausea, vomiting, diarrhea, and abdominal discomfort, although some users may experience them more intensely on Wegovy due to the higher doses used for weight loss.
Wegovy is more focused on weight loss and is approved for that purpose, while Ozempic is primarily used for managing type 2 diabetes. For weight loss, Wegovy can be taken by individuals with a BMI over 30, or over 27 if they have additional health-related conditions.
Both are diabetes medications but have significant off-label use for weight loss. Mounjaro‘s dual action often results in higher weight loss than Ozempic, though the side effects may be more pronounced due to its broader receptor activity.
Mounjaro and Zepbound are both brand names for tirzepatide. The main difference is their regulatory approval:
Wegovy and Zepbound are different drugs that both aim to help with weight loss. Wegovy (semaglutide) is a GLP-1 receptor agonist, while Zepbound (tirzepatide) activates both GLP-1 and GIP receptors. This dual-action mechanism means Zepbound may be more effective for weight loss in clinical trials, though individual results can vary.
Both semaglutide (in Wegovy and Ozempic) and tirzepatide (in Mounjaro and Zepbound) have been proven to support weight loss. However, they haven’t been compared directly until recently. Preliminary studies suggest tirzepatide may offer greater weight loss, but it can also come with more side effects.
For adults with type 2 diabetes, Ozempic or Mounjaro might be the most suitable options, while for those primarily interested in weight loss, Wegovy or Zepbound are the better choices.
| Medication | Weekly Cost | Monthly Cost | Discounted 3-Month Offer |
|---|---|---|---|
| Mounjaro | $87 – $125 | $350 – $600 | $1,050 |
| Zepbound | $87 – $125 | $350 – $600 | $1,050 |
| Wegovy | $50 – $87.50 | $200 – $350 | $600 |
| Ozempic | $50 – $87.50 | $200 – $350 | $600 |
The injection site for weight loss medications like Mounjaro, Ozempic, Wegovy, and Zepbound is typically subcutaneous, meaning the medication is injected under the skin. This is done using a pre-filled pen or syringe, and the most common areas for injection include:
Each of these areas provides a layer of fatty tissue that helps absorb the medication. It’s important to rotate the injection site with each dose to reduce the risk of irritation or scar tissue formation. Always follow the specific instructions provided by your healthcare provider on how to properly administer these injections.
Injectable medications like Mounjaro, Wegovy and Ozempic, Zepbound are designed for self-administration, making it easier to incorporate into your routine with minimal discomfort.
Which medication is best for weight loss, Mounjaro or Wegovy?”
“How much does Ozempic cost without insurance?”
Users often discuss the effectiveness of Mounjaro, Ozempic, and Wegovy. Some prefer Mounjaro for faster results, while others opt for Ozempic due to fewer side effects.
“Best weight loss doctors in NYC?”
Learn More About: Mounjaro First Week Side Effects: What to Expect During Your First 7 Days on Tirzepatide
Dr. Sergey Terushkin is a leading weight loss doctor in New York, specializing in both surgical and non-surgical solutions, including injectable medications like Mounjaro, Ozempic, Wegovy, and Zepbound. With his expertise, patients receive personalized weight loss plans that combine medication, diet, and exercise to effectively manage obesity and type 2 diabetes. Dr. Terushkin’s holistic approach and commitment to patient care make him a top choice for individuals seeking professional weight management in New York. Call Today (347) 830-3003 To Get Started On Your Weight Loss Journey!
Injectable weight loss drugs like Mounjaro, Ozempic, Wegovy, and Zepbound offer promising solutions for those struggling with obesity or diabetes. Choosing between them depends on your individual health needs, costs, insurance coverage, and goals. Consulting with a weight loss specialist at clinics such as Goal BMI Clinic can help determine the best treatment plan tailored to your needs.
Lear more about Rebound Weight Gain After Stopping Tirzepatide (Mounjaro or Zepbound)
At GoalBMI – General & Bariatric Surgery in Brooklyn, NY, we provide comprehensive bariatric surgery, minimally invasive general surgery, and physician-supervised medical weight loss with personalized treatment plans designed around each patient's health goals and long-term success.
Our experienced surgical team includes Dr. Sergey Terushkin, MD, FACS and Dr. Alexander Abdurakhmanov, MD , who work together to deliver advanced bariatric surgery, minimally invasive general surgery, panniculectomy after significant weight loss, hernia repair, gallbladder surgery, and comprehensive obesity care.
Every treatment plan is individualized using evidence-based medicine, modern surgical techniques, and compassionate patient care. From your first consultation through recovery and long-term follow-up, our team is committed to helping you achieve safer surgery, faster recovery, and lasting results.